HCM - ハチソン・チャイナ・メディテック (Hutchison China MediTech Limited) ハチソン・チャイナ・メディテック

 HCMのチャート


 HCMの企業情報

symbol HCM
会社名 Hutchison China Meditech Ltd (ハチソン・チャイナ・メディテック)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   ハチソン・チャイナ・メディテックはケイマン諸島籍で中国医薬品メ―カ―。主に抗がん剤や自己免疫疾患治療向けの医薬品の開発・製造・販売に従事する。また、植物成分に由来する中国伝統の漢方薬、健康補助食品、オ―ガニック食品ヘルスケア用品、パ―ソナルケア用品なども取り扱う。本社所在地は香港。   
本社所在地 22/F Hutchison House 10 Harcourt Road HKG
代表者氏名
代表者役職名
電話番号
設立年月日 36861
市場名 NASDAQ National Market System
ipoyear 2016年
従業員数 590人
url www.chi-med.com
nasdaq_url https://www.nasdaq.com/symbol/hcm
adr_tso 29546022
EBITDA EBITDA ー
終値(lastsale) 30.42
時価総額(marketcap) 898789989.24
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 HCMのテクニカル分析


 HCMのニュース

   Hutchison China MediTech Analysts Estimate Report : What to Look Out for Stock market Insights & financial analysis  2021/03/03 18:11:00 Stock Market Daily
Hutchison China MediTech announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases - Stocks News Feed  2021/01/11 01:00:00 Stocks News Feed
HONG KONG, SHANGHAI, China, SAN DIEGO & FLORHAM PARK, N.J., Jan. 10, 2021 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med“) (Nasdaq/AIM: HCM) and Inmagene Biopharmaceuticals (“Inmagene”) today announce a strategic partnership to further develop four novel preclinical drug candidates discovered by Chi-Med for the potential treatment of multiple immunological diseases. Funded by Inmagene, the… Read More »Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases
   Howden Group Holdings launches Howden Capital Markets (“HCM”) - ...  2021/01/08 08:19:00 Global Reinsurance
HCM is a new capital markets adviser with a clear ambition to develop innovative products to service clients, markets and investors.
   Internal Team Purchases Human Capital Media, Owner Of Chief Learning Officer And Talent Management, Relaunches As Betterwork Media Group, Resurrects Talent Management Brand  2021/01/06 13:00:00 PR Newswire
CHICAGO, Jan. 6, 2021 /PRNewswire/ -- Ana Dirksen, Kevin Fields, Ashley St. John and Lauren Wilbur of Human Capital Media (HCM), an integrated media and market-intelligence company focused on talent management, development and growth, have purchased HCM and relaunched as BetterWork Media…
   Hutchison China MediTech Limited (NASDAQ:HCM) Receives Consensus Recommendation of “Buy” from Analysts  2020/10/22 09:48:42 Zolmax News
Hutchison China MediTech Limited (NASDAQ:HCM) has received an average rating of “Buy” from the eight ratings firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year target price among brokerages […]
   Hutchison China MediTech Analysts Estimate Report : What to Look Out for Stock market Insights & financial analysis  2021/03/03 18:11:00 Stock Market Daily
Hutchison China MediTech announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases - Stocks News Feed  2021/01/11 01:00:00 Stocks News Feed
HONG KONG, SHANGHAI, China, SAN DIEGO & FLORHAM PARK, N.J., Jan. 10, 2021 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med“) (Nasdaq/AIM: HCM) and Inmagene Biopharmaceuticals (“Inmagene”) today announce a strategic partnership to further develop four novel preclinical drug candidates discovered by Chi-Med for the potential treatment of multiple immunological diseases. Funded by Inmagene, the… Read More »Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases
   Howden Group Holdings launches Howden Capital Markets (“HCM”) - ...  2021/01/08 08:19:00 Global Reinsurance
HCM is a new capital markets adviser with a clear ambition to develop innovative products to service clients, markets and investors.
   Internal Team Purchases Human Capital Media, Owner Of Chief Learning Officer And Talent Management, Relaunches As Betterwork Media Group, Resurrects Talent Management Brand  2021/01/06 13:00:00 PR Newswire
CHICAGO, Jan. 6, 2021 /PRNewswire/ -- Ana Dirksen, Kevin Fields, Ashley St. John and Lauren Wilbur of Human Capital Media (HCM), an integrated media and market-intelligence company focused on talent management, development and growth, have purchased HCM and relaunched as BetterWork Media…
   Hutchison China MediTech Limited (NASDAQ:HCM) Receives Consensus Recommendation of “Buy” from Analysts  2020/10/22 09:48:42 Zolmax News
Hutchison China MediTech Limited (NASDAQ:HCM) has received an average rating of “Buy” from the eight ratings firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year target price among brokerages […]
   Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases - Stocks News Feed  2021/01/11 01:00:00 Stocks News Feed
HONG KONG, SHANGHAI, China, SAN DIEGO & FLORHAM PARK, N.J., Jan. 10, 2021 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med“) (Nasdaq/AIM: HCM) and Inmagene Biopharmaceuticals (“Inmagene”) today announce a strategic partnership to further develop four novel preclinical drug candidates discovered by Chi-Med for the potential treatment of multiple immunological diseases. Funded by Inmagene, the… Read More »Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases
   Howden Group Holdings launches Howden Capital Markets (“HCM”) - ...  2021/01/08 08:19:00 Global Reinsurance
HCM is a new capital markets adviser with a clear ambition to develop innovative products to service clients, markets and investors.
   Internal Team Purchases Human Capital Media, Owner Of Chief Learning Officer And Talent Management, Relaunches As Betterwork Media Group, Resurrects Talent Management Brand  2021/01/06 13:00:00 PR Newswire
CHICAGO, Jan. 6, 2021 /PRNewswire/ -- Ana Dirksen, Kevin Fields, Ashley St. John and Lauren Wilbur of Human Capital Media (HCM), an integrated media and market-intelligence company focused on talent management, development and growth, have purchased HCM and relaunched as BetterWork Media…
   Hutchison China MediTech Limited (NASDAQ:HCM) Receives Consensus Recommendation of “Buy” from Analysts  2020/10/22 09:48:42 Zolmax News
Hutchison China MediTech Limited (NASDAQ:HCM) has received an average rating of “Buy” from the eight ratings firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year target price among brokerages […]
   Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London  2020/10/01 10:30:08 South China Morning Post
Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to receive approvals to sell its endocrine and lung cancer drugs in China by June next year, chief executive officer Christian Hogg said.The cancer drugs manufacturing and innovation unit of billionaire Li Ka-shing‘s conglomerate CK Hutchison, plans to triple the size of its marketing team over the next three years in anticipation of the green light, he added. That will take the…

 関連キーワード  (― 米国株 ハチソン・チャイナ・メディテック HCM Hutchison China MediTech Limited)

 twitter  (公式ツイッターやCEOツイッターなど)